spironolactone has been researched along with Adrenal Cortex Cancer in 43 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case of primary aldosteronism is presented in which the CT scan was initially misleading, adrenocortical scintigraphy was rendered inaccurate by pharmacological interference of spironolactone, and selective adrenal venous sampling of aldosterone was technically difficult." | 7.69 | Interference by spironolactone on adrenocortical scintigraphy and other pitfalls in the location of adrenal abnormalities in primary aldosteronism. ( Freitas, JE; Grekin, R; Gross, MD; Shapiro, B, 1994) |
| "So-called Spironolactone bodies are reported in four adrenal cortical adenomas that were removed from patients with primary hyperaldosteronism, treated preoperatively with spironolactone." | 7.66 | [Spironolactone bodies. Light and electron microscope study apropos of 4 cases of adrenal adenomas with primary hyperaldosteronism]. ( Abelanet, R; Daudet-Monsac, M; Lellouch-Tubiana, A; Louvel, A; Vacher-Lavenu, MC, 1982) |
| "Spironolactone bodies were observed in an adrenal cortical adenoma that was removed from a patient with primary hyperaldosteronism (Conn syndrome) treated preoperatively with spironolactone." | 7.65 | Spironolactone bodies in an adrenal adenoma. ( Cooper, PH; Shrago, SS; Waisman, J, 1975) |
| "Mitotane TR was significantly reduced in the SPL group, as was time-in-range to progression." | 5.72 | Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients. ( Haberbosch, L; Jumpertz von Schwartzenberg, R; Mai, K; Maurer, L; Sandforth, A; Spranger, J; Wernicke, C, 2022) |
| "Rhabdomyolysis is a rare presentation of hypokalemia, although muscle weakness is a well known manifestation of marked hypokalemia." | 5.35 | An unusual case of an aldosterone-producing adrenocortical adenoma presenting with rhabdomyolysis. ( Ahmetoğlu, A; Bahat, E; Imamoğlu, M; Karagüzel, G; Okten, A; Yildiz, K, 2009) |
| "We report a rare case of adrenocortical carcinoma." | 5.32 | Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma. ( Azizlerli, H; Kapran, Y; Kurtulmus, N; Yarman, S, 2004) |
| "Twenty patients suffering from primary hyperaldosteronism were studied." | 5.26 | [The renin-angiotensin-aldosterone system in hypertensive patients. II. Diagnosis of primary hyperaldosteronism]. ( Benguigui, L; Corvol, P; Houde, M; Menard, J; Milliez, P; Tonnelier, M, 1977) |
| "A case of primary aldosteronism is presented in which the CT scan was initially misleading, adrenocortical scintigraphy was rendered inaccurate by pharmacological interference of spironolactone, and selective adrenal venous sampling of aldosterone was technically difficult." | 3.69 | Interference by spironolactone on adrenocortical scintigraphy and other pitfalls in the location of adrenal abnormalities in primary aldosteronism. ( Freitas, JE; Grekin, R; Gross, MD; Shapiro, B, 1994) |
| "So-called Spironolactone bodies are reported in four adrenal cortical adenomas that were removed from patients with primary hyperaldosteronism, treated preoperatively with spironolactone." | 3.66 | [Spironolactone bodies. Light and electron microscope study apropos of 4 cases of adrenal adenomas with primary hyperaldosteronism]. ( Abelanet, R; Daudet-Monsac, M; Lellouch-Tubiana, A; Louvel, A; Vacher-Lavenu, MC, 1982) |
| "Spironolactone bodies were observed in an adrenal cortical adenoma that was removed from a patient with primary hyperaldosteronism (Conn syndrome) treated preoperatively with spironolactone." | 3.65 | Spironolactone bodies in an adrenal adenoma. ( Cooper, PH; Shrago, SS; Waisman, J, 1975) |
| "The identification of primary aldosteronism as a common cause of resistant hypertension is a significant advance in our ability to care for patients with hypertension." | 2.49 | Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism. ( Weiner, ID, 2013) |
| "Primary hyperaldosteronism (PHA) is characterized by an increased Aldosterone synthesis which is independent of the Renin-Angiotensin-Aldosterone-System (RAAS)." | 2.48 | [Primay hyperaldosteronism--diagnostic and treatment]. ( Beuschlein, F; Potthoff, SA; Vonend, O, 2012) |
| "Primary hyperaldosteronism will be the most common etiology." | 2.47 | [Primary hyperaldosteronism]. ( Chambaz, IC; Pechère-Bertschi, A, 2011) |
| "Adrenal cortical carcinoma is a rare endocrine tumor, and complete surgical resection is the only potentially curative treatment." | 2.41 | Adrenal cortical carcinoma. ( Boushey, RP; Dackiw, AP, 2001) |
| "Mitotane TR was significantly reduced in the SPL group, as was time-in-range to progression." | 1.72 | Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients. ( Haberbosch, L; Jumpertz von Schwartzenberg, R; Mai, K; Maurer, L; Sandforth, A; Spranger, J; Wernicke, C, 2022) |
| "Primary aldosteronism (PA, also Conn syndrome) is a benign disease in majority of cases." | 1.40 | Predictors of malignancy in primary aldosteronism. ( Agha, A; Haneya, A; Hornung, M; Iesalnieks, I; Jung, EM; Schlitt, HJ; Schreyer, A, 2014) |
| "Rhabdomyolysis is a rare presentation of hypokalemia, although muscle weakness is a well known manifestation of marked hypokalemia." | 1.35 | An unusual case of an aldosterone-producing adrenocortical adenoma presenting with rhabdomyolysis. ( Ahmetoğlu, A; Bahat, E; Imamoğlu, M; Karagüzel, G; Okten, A; Yildiz, K, 2009) |
| "We report a rare case of adrenocortical carcinoma." | 1.32 | Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma. ( Azizlerli, H; Kapran, Y; Kurtulmus, N; Yarman, S, 2004) |
| "Two clinical cases of women with primary hyperaldosteronism are reported." | 1.28 | [2 cases of primary hyperaldosteronism]. ( Dodev, K; Kolarski, V; Nakov, N; Rashkov, R; Vladov, V, 1991) |
| "Treatment with spironolactone, mitotane, or aminoglutethimide had transient clinical effects." | 1.27 | Aldosterone-producing adrenocortical carcinoma. Preoperative recognition and course in three cases. ( Arteaga, E; Biglieri, EG; Kater, CE; Lopez, JM; Schambelan, M, 1984) |
| "Spironolactone was administered in 6 of these patients, but not in the remaining patient." | 1.27 | Ultrastructural studies of adrenal adenoma causing primary aldosteronism. ( Kumazawa, J; Kuramoto, H, 1985) |
| "Twenty patients suffering from primary hyperaldosteronism were studied." | 1.26 | [The renin-angiotensin-aldosterone system in hypertensive patients. II. Diagnosis of primary hyperaldosteronism]. ( Benguigui, L; Corvol, P; Houde, M; Menard, J; Milliez, P; Tonnelier, M, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (41.86) | 18.7374 |
| 1990's | 5 (11.63) | 18.2507 |
| 2000's | 8 (18.60) | 29.6817 |
| 2010's | 11 (25.58) | 24.3611 |
| 2020's | 1 (2.33) | 2.80 |
| Authors | Studies |
|---|---|
| Haberbosch, L | 1 |
| Maurer, L | 1 |
| Sandforth, A | 1 |
| Wernicke, C | 1 |
| Spranger, J | 1 |
| Mai, K | 1 |
| Jumpertz von Schwartzenberg, R | 1 |
| Weiner, ID | 1 |
| Petramala, L | 1 |
| Savoriti, C | 1 |
| Zinnamosca, L | 1 |
| Marinelli, C | 1 |
| Settevendemmie, A | 1 |
| Calvieri, C | 1 |
| Catani, M | 1 |
| Letizia, C | 1 |
| Agha, A | 1 |
| Hornung, M | 1 |
| Iesalnieks, I | 1 |
| Schreyer, A | 1 |
| Jung, EM | 1 |
| Haneya, A | 1 |
| Schlitt, HJ | 1 |
| Riester, A | 1 |
| Reincke, M | 1 |
| Beuschlein, F | 2 |
| Wu, CH | 1 |
| Yang, YW | 1 |
| Hung, SC | 1 |
| Tsai, YC | 1 |
| Hu, YH | 1 |
| Lin, YH | 1 |
| Chu, TS | 1 |
| Wu, KD | 1 |
| Wu, VC | 1 |
| Karagüzel, G | 1 |
| Bahat, E | 1 |
| Imamoğlu, M | 1 |
| Ahmetoğlu, A | 1 |
| Yildiz, K | 1 |
| Okten, A | 1 |
| Katayama, A | 1 |
| Otsuka, F | 1 |
| Tanabe, K | 1 |
| Tsukamoto, N | 1 |
| Yamanaka, R | 1 |
| Matsumoto, Y | 1 |
| Nasu, Y | 1 |
| Makino, H | 1 |
| Fikri Benbrahim, O | 1 |
| García Agudo, R | 1 |
| Cazalla Cadenas, F | 1 |
| Martínez Calero, A | 1 |
| González-Spínola, J | 1 |
| Krysiak, R | 1 |
| Okopien, B | 1 |
| Chambaz, IC | 1 |
| Pechère-Bertschi, A | 1 |
| Cabassi, A | 1 |
| Rocco, R | 1 |
| Berretta, R | 1 |
| Regolisti, G | 1 |
| Bacchi-Modena, A | 1 |
| Potthoff, SA | 1 |
| Vonend, O | 1 |
| Stephany, JD | 1 |
| Pearl, GS | 1 |
| NORTH, JD | 1 |
| SIMS, FH | 1 |
| SAYERS, EG | 1 |
| GADRAT, J | 1 |
| DELAUDE, A | 1 |
| JORDA, MF | 1 |
| MOREAU, G | 1 |
| MOBLEY, JE | 1 |
| HEADSTREAM, JW | 1 |
| MELBY, J | 1 |
| Kurtulmus, N | 1 |
| Yarman, S | 1 |
| Azizlerli, H | 1 |
| Kapran, Y | 1 |
| Ribstein, J | 1 |
| Du Cailar, G | 1 |
| Fesler, P | 1 |
| Mimran, A | 1 |
| Satoh, F | 1 |
| Ito, S | 1 |
| Carmona-Bayonas, A | 1 |
| Soler, IO | 1 |
| Gómez, FI | 1 |
| Billalabeitia, EG | 1 |
| Saura, HP | 1 |
| Tafalla, MS | 1 |
| Díaz, MP | 1 |
| Arteaga, E | 1 |
| Biglieri, EG | 1 |
| Kater, CE | 1 |
| Lopez, JM | 1 |
| Schambelan, M | 1 |
| Vacher-Lavenu, MC | 1 |
| Lellouch-Tubiana, A | 1 |
| Louvel, A | 1 |
| Daudet-Monsac, M | 1 |
| Abelanet, R | 1 |
| Greathouse, DJ | 1 |
| McDermott, MT | 1 |
| Kidd, GS | 1 |
| Hofeldt, FD | 1 |
| Aiba, M | 1 |
| Suzuki, H | 1 |
| Kageyama, K | 1 |
| Murai, M | 1 |
| Tazaki, H | 1 |
| Abe, O | 1 |
| Saruta, T | 1 |
| Shapiro, B | 1 |
| Grekin, R | 2 |
| Gross, MD | 1 |
| Freitas, JE | 2 |
| Rossi, E | 1 |
| Sani, C | 1 |
| Perazzoli, F | 1 |
| Casoli, MC | 1 |
| Negro, A | 1 |
| Dotti, C | 1 |
| Ganguly, A | 1 |
| Al Saad, KO | 1 |
| Chan, NH | 1 |
| Boushey, RP | 1 |
| Dackiw, AP | 1 |
| Shrago, SS | 1 |
| Waisman, J | 1 |
| Cooper, PH | 1 |
| McGuffin, WL | 1 |
| Gunnells, JC | 1 |
| Ibayashi, H | 1 |
| Takasugi, M | 1 |
| Albert, JP | 1 |
| Wronski, R | 1 |
| Jentzen, F | 1 |
| Hartmann, F | 1 |
| Ferriss, JB | 1 |
| Beevers, DG | 1 |
| Boddy, K | 1 |
| Brown, JJ | 1 |
| Davies, DL | 1 |
| Fraser, R | 1 |
| Kremer, D | 1 |
| Lever, AF | 1 |
| Robertson, JI | 1 |
| Rifai, A | 1 |
| Beierwaltes, WH | 1 |
| Salvador, M | 1 |
| Berthoumieu, H | 1 |
| Louvet, JP | 1 |
| Conte, JJ | 1 |
| Guittard, J | 1 |
| Suc, JM | 1 |
| Corvol, P | 1 |
| Houde, M | 1 |
| Benguigui, L | 1 |
| Tonnelier, M | 1 |
| Menard, J | 1 |
| Milliez, P | 1 |
| Conn, JW | 1 |
| Hinerman, DL | 1 |
| Nakov, N | 1 |
| Vladov, V | 1 |
| Kolarski, V | 1 |
| Dodev, K | 1 |
| Rashkov, R | 1 |
| Deng, Y | 1 |
| Osamura, Y | 1 |
| Tanaka, M | 1 |
| Katsuoka, Y | 1 |
| Kawamura, N | 1 |
| Murakoshi, M | 1 |
| Kuramoto, H | 1 |
| Kumazawa, J | 1 |
| Stimpel, M | 1 |
| Dralle, H | 1 |
| von zur Mühlen, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Postoperative Cardiovascular Index Change of Primary Aldosteronism[NCT00746070] | 300 participants (Actual) | Observational | 2007-01-31 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for spironolactone and Adrenal Cortex Cancer
| Article | Year |
|---|---|
Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Eplerenone; Humans; Hy | 2013 |
[Primary hyperaldosteronism: boundaries of diagnostics and therapy].
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adrenocortical Hyperfunction; Aldos | 2014 |
[Primary hyperaldosteronism].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Algorithms; Humans; Hyperaldosteronism; Hypertensi | 2011 |
[Primay hyperaldosteronism--diagnostic and treatment].
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenocortical Adenoma; A | 2012 |
[Adrenocortical adenoma].
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Androgens; Biomarkers; | 2006 |
Primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Diagnosis, Differential; Humans; Hype | 1998 |
Adrenal cortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Algorithms; Antineoplastic Agents; Carcinoma; Chemot | 2001 |
Primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; | 1977 |
[Primary aldosteronism--aldosterone-induced sodium storing hypertension--symptoms and differential diagnosis].
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Alkalosis; Animals; Diagnosis, Differential; Dogs; F | 1979 |
1 trial available for spironolactone and Adrenal Cortex Cancer
| Article | Year |
|---|---|
Effect of Treatment on Body Fluid in Patients with Unilateral Aldosterone Producing Adenoma: Adrenalectomy versus Spironolactone.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aged; Aged, 80 and over; Aldosteron | 2015 |
33 other studies available for spironolactone and Adrenal Cortex Cancer
| Article | Year |
|---|---|
Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Agents, Hormonal; Humans; Male; M | 2022 |
Primary aldosteronism with concurrent primary hyperparathyroidism in a patient with arrhythmic disorders.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Arrhythmias, Cardiac; Electr | 2013 |
Predictors of malignancy in primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Aged; Aldosterone; Cell Transformation, Neoplastic; Female; | 2014 |
An unusual case of an aldosterone-producing adrenocortical adenoma presenting with rhabdomyolysis.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldoste | 2009 |
Unexpected occurrence of adrenal Cushing's syndrome in a patient with systemic lupus erythematosus.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Angiomyolipoma; Antihyperten | 2011 |
[Diagnosis of secondary hypertension causing miscarriage during the first trimester of pregnancy].
Topics: Abortion, Spontaneous; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Antihypertensive Age | 2011 |
The effect of treatment on monocyte and lymphocyte cytokine release in patients with aldosteronoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Blood Pressure; | 2012 |
Eplerenone use in primary aldosteronism during pregnancy.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Eplerenone; Female; Follow-U | 2012 |
Pathologic quiz case: an adrenal mass in a 54-year-old man.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Humans; Inclusion Bodies; Male; Middle Aged; Spiro | 2003 |
Primary aldosteronism. The value of spironolactone in diagnosis.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Lactones; Spirono | 1961 |
[Conn's syndrome with adrenocortical adenoma. Action of spirolactone, SC-9420].
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Diuretics; Humans; Hy | 1962 |
Primary aldosteronism. Preoperative preparation with spironolactone.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid | 1962 |
Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aldosterone; Diuretics; Female; Histocyto | 2004 |
Relative glomerular hyperfiltration in primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aged; Blood Pressure; Female; Glomerular Filtration Rate; | 2005 |
Tailored hormonal therapy in secretory adrenocortical cancer.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Aged; Aldosterone; Alkalosis; Ang | 2007 |
Aldosterone-producing adrenocortical carcinoma. Preoperative recognition and course in three cases.
Topics: Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Adult; Circadian Rhythm; Female; Glucocortico | 1984 |
[Spironolactone bodies. Light and electron microscope study apropos of 4 cases of adrenal adenomas with primary hyperaldosteronism].
Topics: Adenoma; Adrenal Cortex Neoplasms; Humans; Hyperaldosteronism; Inclusion Bodies; Microscopy, Electro | 1982 |
Pure primary hyperaldosteronism due to adrenal cortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Calcinosis; Carcinoma; Female; Humans; Hyperaldosteronism; Hypertension; H | 1984 |
Spironolactone bodies in aldosteronomas and in the attached adrenals. Enzyme histochemical study of 19 cases of primary aldosteronism and a case of aldosteronism due to bilateral diffuse hyperplasia of the zona glomerulosa.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Animals; Female; Histocytochemistry; Humans; | 1981 |
Interference by spironolactone on adrenocortical scintigraphy and other pitfalls in the location of adrenal abnormalities in primary aldosteronism.
Topics: Adosterol; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Dexamethasone; Humans; Hyperaldosteroni | 1994 |
Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Analysis | 1995 |
Test and teach. Surgically correctable hypertension. Conn's syndrome and spironolactone bodies.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertens | 2001 |
Spironolactone bodies in an adrenal adenoma.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Endoplasmic Reticulum; H | 1975 |
[Plasma aldosterone and electrolytes in primary and secondard aldosteronism (author's transl)].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Ascites; Electrolytes; Female; Humans; Hypera | 1979 |
The treatment of low-renin ("primary") hyperaldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Amiloride; Blood Pressure; Dexamethasone; Female; | 1978 |
Adrenal scintigraphy in low renin essential hypertension.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Blood Pressure; Dexamethasone; Female; Hum | 1978 |
[Primary and idiopathic hyperaldosteronism. Course 1 year after operation. Apropos of 28 cases].
Topics: Adrenal Cortex Neoplasms; Biopsy; Female; Humans; Hyperaldosteronism; Hypertension; Kidney; Male; Mi | 1976 |
[The renin-angiotensin-aldosterone system in hypertensive patients. II. Diagnosis of primary hyperaldosteronism].
Topics: Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Hyperfunction; Adult; Aldosterone; Blo | 1977 |
Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; | 1977 |
[2 cases of primary hyperaldosteronism].
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Combined Modality Therapy; Female; Humans; Hyperaldosteron | 1991 |
A case of testosterone-secreting adrenal cortical adenoma with spironolactone body-like inclusion.
Topics: Acid Phosphatase; Adenoma; Adolescent; Adrenal Cortex Neoplasms; Female; Histocytochemistry; Humans; | 1990 |
Ultrastructural studies of adrenal adenoma causing primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Cell Nucleus; Endoplasmic Reticulum; Female; Humans; Hyper | 1985 |
[Therapy of primary aldosteronism].
Topics: Adenoma; Adrenal Cortex Diseases; Adrenal Cortex Neoplasms; Adrenalectomy; Carcinoma; Diagnosis, Dif | 1986 |